The anti-depressant drug fluvoxamine is being looked at by researchers as a possible treatment for COVID-19. A recently released study found the drug showed a reduced risk of hospitalization and death among COVID patients. However, the researchers concluded that more research is needed.
Health.com reported that experts believe fluvoxamine has shown to be effective against COVID-19 due to the medication's effects on the body's inflammatory response-specifically by tamping down that response in those with active COVID-19 infections.
/University Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
